Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis

Código QR

Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis

VF Fragoulakis,1 AG Pallis,3 DK Kaitelidou,2 NM Maniadakis,1 VG Georgoulias31Department of Health Services Management, National School of Public Health, Athens, 2Center for Health Services Management and Evaluation, Department of Nursing, University of Athens, Athens, Greece; 3Department of Medical...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fragoulakis VF, Pallis AG, Kaitelidou DK, Maniadakis NM, Georgoulias VG
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/f1f1582fdeaf40538ee1ef2b7b85cfe5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Potential role of pemetrexed in metastatic breast cancer patients pre-treated with anthracycline or taxane
por: Li-Yan Zhou, et al.
Publicado: (2015)

Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices
por: Vamsidhar Velcheti, et al.
Publicado: (2021)

Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.
por: Daniel A Monti, et al.
Publicado: (2012)

Combination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer.
por: Jasmine G Lee, et al.
Publicado: (2012)

Erlotinib in the treatment of advanced pancreatic cancer
por: Robin K Kelley, et al.
Publicado: (2008)

Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
por: Hongfu Cai, et al.
Publicado: (2021)

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
por: Schuette W, et al.
Publicado: (2017)

Cost-Effectiveness Analysis of Pembrolizumab Plus Pemetrexed and Platinum Versus Chemotherapy Alone as First-Line Treatment in Metastatic Non-Squamous Non–Small Cell Lung Cancer: A Reconstruction of Partitioned Survival Model Based on Time Dependent Pricing Mechanism of Patient Assistance Program
por: Yuanyi Cai, et al.
Publicado: (2021)

Implications of COVID-19 Restriction Measures in Urban Air Quality of Thessaloniki, Greece: A Machine Learning Approach
por: Dimitris Akritidis, et al.
Publicado: (2021)

Greece & Rome

Rapidly Progressive Lung Sarcomatoid Carcinoma Managed with Doxorubicin Plus Ifosfamide and Pemetrexed
por: Jan Alberto Paredes Mogica, et al.
Publicado: (2021)

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study
por: Cova E, et al.
Publicado: (2019)

First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors
por: Nguyen KS, et al.
Publicado: (2012)

OPTIMIZATION MODELS PERFORMANCES FOR TRANSPORTATION COST MINIMIZATION
por: Fevzi Serkan ÖZDEMİR, et al.
Publicado: (2021)

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
por: Nobukazu Fujimoto, et al.
Publicado: (2021)

A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC
por: Madeline Krentz Gober, et al.
Publicado: (2017)

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
por: Al-Keilani MS, et al.
Publicado: (2018)

Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
por: Minami S, et al.
Publicado: (2015)

Pemetrexed-based first-line chemotherapy had particularly prominent objective response rate for advanced NSCLC: A network meta-analysis
por: Lv Yuankai, et al.
Publicado: (2021)

EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer.
por: Florent Baty, et al.
Publicado: (2013)

Metronomic delivery of orally available pemetrexed-incorporated colloidal dispersions for boosting tumor-specific immunity
por: Ruby Maharjan, et al.
Publicado: (2021)

Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study
por: Chun-Hua Zhou, et al.
Publicado: (2021)

Second-line systemic therapy for metastatic colorectal cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
por: Aygel R. Zaleeva
Publicado: (2021)

Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era
por: Isaac E. Kim, et al.
Publicado: (2021)

Greece and the Limits of European Solidarity
por: Glyn Morgan
Publicado: (2015)

Minimizing the cost of a curved corner trapezoidal canal section
por: Ehab M. Fattouh, et al.
Publicado: (2021)

High-speed devices for modular reduction with minimal hardware costs
por: S. Tynymbayev, et al.
Publicado: (2019)

Freehand Minimally Invasive Pedicle Screw Fixation and Minimally Invasive Decompression for a Thoracic or Lumbar Vertebral Metastatic Tumor From Hepatocellular Carcinoma
por: Wenshuai Fan, et al.
Publicado: (2021)

Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer
por: Bai F, et al.
Publicado: (2018)

Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib.
por: Gang Chen, et al.
Publicado: (2013)

Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
por: Lan MY, et al.
Publicado: (2020)

Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
por: Karachaliou N, et al.
Publicado: (2014)

Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma.
por: Jeng-Sen Tseng, et al.
Publicado: (2014)

Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma
por: Xiaoyu Zhai, et al.
Publicado: (2017)

Erlotinib eradicates brain metastases from epidermal growth factor receptor mutant non-small cell lung cancer
por: Siavash Jabbari, et al.
Publicado: (2011)

Correlation between MTHFR 677C > T polymorphism and response of pemetrexed-based chemotherapy in advanced NSCLC: A meta-analysis
por: Han Feng, et al.
Publicado: (2021)

Selection of suppliers of repairable equipment with the aim of minimizing costs in the construction and operation phases
por: Mohammadjavad Shamsi, et al.
Publicado: (2020)

Minimization of Cost of Energy with Renewable Energy Sources by using Fire-Fly Algorithm
por: Shaik Karimulla, et al.
Publicado: (2021)

Valuing Goods: The Development of Commensurability in Archaic Greece
por: Mark Peacock
Publicado: (2021)

Socialising the Landscape in the Early Neolithic of Thessaly, Greece
por: Souvatzi Stella, et al.
Publicado: (2021)